MSC Industrial Direct Co Inc
MSMNYSECIK 1003078Consumer discretionaryFiscal year ends Aug 29
Reports and events: 337 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2019-05-1616:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001003078-19-000106 |
| 2019-04-1014:43 ET | 10-Q | Quarterly reportPeriod 2019-03-02 | 0001003078-19-000100 |
| 2019-04-1006:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001003078-19-000098 |
| 2019-03-2717:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-19-000080 |
| 2019-01-2916:20 ET | 8-K | 5.07 Shareholder vote results | 0001003078-19-000056 |
| 2019-01-0915:13 ET | 10-Q | Quarterly reportPeriod 2018-12-01 | 0001003078-19-000035 |
| 2019-01-0906:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001003078-19-000032 |
| 2018-12-1908:53 ET | DEF 14A | Proxy statementPeriod 2019-01-29 | 0001003078-18-000322 |
| 2018-12-1917:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-18-000318 |
| 2018-12-1307:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001003078-18-000313 |
| 2018-11-0116:41 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001003078-18-000303 |
| 2018-10-3016:16 ET | 10-K | Annual reportPeriod 2018-09-01 | 0001003078-18-000281 |
| 2018-10-3006:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001003078-18-000275 |
| 2018-10-1816:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-18-000220 |
| 2018-07-2717:35 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-18-000174 |
| 2018-07-1115:19 ET | 10-Q | Quarterly reportPeriod 2018-06-02 | 0001003078-18-000170 |
| 2018-07-1106:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001003078-18-000168 |
| 2018-06-1917:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-18-000162 |
| 2018-04-1015:15 ET | 10-Q | Quarterly reportPeriod 2018-03-03 | 0001003078-18-000116 |
| 2018-04-1006:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001003078-18-000114 |
| 2018-04-0618:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-18-000109 |
| 2018-01-2609:10 ET | 8-K | 5.07 Shareholder vote results | 0001003078-18-000050 |
| 2018-01-1708:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001003078-18-000016 |
| 2018-01-1016:19 ET | 10-Q | Quarterly reportPeriod 2017-12-02 | 0001003078-18-000011 |
| 2018-01-1006:52 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-18-000009 |
| 2018-01-0308:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-18-000005 |
| 2017-12-1508:25 ET | DEF 14A | Proxy statementPeriod 2018-01-25 | 0001003078-17-000314 |
| 2017-10-3115:23 ET | 10-K | Annual reportPeriod 2017-09-02 | 0001003078-17-000307 |
| 2017-10-3106:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001003078-17-000305 |
| 2017-10-2613:56 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-17-000266 |
| 2017-10-2517:37 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-17-000231 |
| 2017-07-1215:20 ET | 10-Q | Quarterly reportPeriod 2017-06-03 | 0001003078-17-000160 |
| 2017-07-1206:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001003078-17-000156 |
| 2017-07-0717:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-17-000152 |
| 2017-04-1810:34 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-17-020829 |
| 2017-04-0615:09 ET | 10-Q | Quarterly reportPeriod 2017-03-04 | 0001003078-17-000112 |
| 2017-04-0606:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001003078-17-000110 |
| 2017-03-3017:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-17-000104 |
| 2017-01-2617:09 ET | 8-K | 5.07 Shareholder vote results | 0001003078-17-000041 |
| 2017-01-1114:46 ET | 10-Q | Quarterly reportPeriod 2016-12-03 | 0001003078-17-000005 |
| 2017-01-1106:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001003078-17-000003 |
| 2016-12-2016:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-16-000378 |
| 2016-12-1606:00 ET | DEF 14A | Proxy statementPeriod 2017-01-26 | 0001144204-16-139835 |
| 2016-11-0115:13 ET | 10-K | Annual reportPeriod 2016-09-03 | 0001003078-16-000362 |
| 2016-11-0106:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001003078-16-000360 |
| 2016-10-2716:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001003078-16-000337 |
| 2016-10-2716:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001144204-16-129908 |
| 2016-08-1909:15 ET | 8-K | 8.01 Other events | 0001144204-16-120279 |
| 2016-07-1216:45 ET | 8-K | 8.01 Other events | 0001003078-16-000246 |
| 2016-07-0616:30 ET | 10-Q | Quarterly reportPeriod 2016-05-28 | 0001003078-16-000244 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 13:25 ET. Listed shows no prices and gives no investment advice.